Bittner VA - Search Results

1

JCL roundtable: lipid-lowering drugs in those older than 75 years of age.

Brown WV, Bittner VA, McKenney JM, Ziajka PE. Brown WV, et al. Among authors: bittner va. J Clin Lipidol. 2014 Nov-Dec;8(6):533-541. doi: 10.1016/j.jacl.2014.09.009. Epub 2014 Sep 28. J Clin Lipidol. 2014. PMID: 25499934

2

Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women.

Brown WV, Wenger N, Bittner V, Brinton E. Brown WV, et al. J Clin Lipidol. 2010 Sep-Oct;4(5):324-34. doi: 10.1016/j.jacl.2010.07.006. Epub 2010 Jul 30. J Clin Lipidol. 2010. PMID: 21122672 No abstract available.

3

Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.

Brown TM, Bittner V. Brown TM, et al. J Clin Lipidol. 2007 Dec;1(6):564-74. doi: 10.1016/j.jacl.2007.10.009. Epub 2007 Oct 22. J Clin Lipidol. 2007. PMID: 21291698

4

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, Brown WV, Cromwell WC, Goldberg RB, McKenney JM, Remaley AT, Sniderman AD, Toth PP, Tsimikas S, Ziajka PE, Maki KC, Dicklin MR. Davidson MH, et al. Among authors: bittner va. J Clin Lipidol. 2011 Sep-Oct;5(5):338-67. doi: 10.1016/j.jacl.2011.07.005. J Clin Lipidol. 2011. PMID: 21981835

5

An assessment by the Statin Cognitive Safety Task Force: 2014 update.

Rojas-Fernandez CH, Goldstein LB, Levey AI, Taylor BA, Bittner V, The National Lipid Association's Safety Task Force. Rojas-Fernandez CH, et al. J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S5-16. doi: 10.1016/j.jacl.2014.02.013. J Clin Lipidol. 2014. PMID: 24793442

6

Lipid-lowering therapy in patients 75 years and older: clinical priority or superfluous therapy?

Phan BA, Bittner V. Phan BA, et al. Prog Cardiovasc Dis. 2014 Sep-Oct;57(2):187-96. doi: 10.1016/j.pcad.2014.03.005. Epub 2014 Mar 12. Prog Cardiovasc Dis. 2014. PMID: 25216618 Review.

7

Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.

Otvos JD, Guyton JR, Connelly MA, Akapame S, Bittner V, Kopecky SL, Lacy M, Marcovina SM, Muhlestein JB, Boden WE. Otvos JD, et al. J Clin Lipidol. 2018 Mar-Apr;12(2):348-355.e2. doi: 10.1016/j.jacl.2018.01.002. Epub 2018 Jan 12. J Clin Lipidol. 2018. PMID: 29409728 Free PMC article. Clinical Trial.

8

PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease.

Bittner VA, Giugliano RP, Brinton EA, Guyton JR. Bittner VA, et al. J Clin Lipidol. 2018 Jul-Aug;12(4):835-843. doi: 10.1016/j.jacl.2018.06.013. J Clin Lipidol. 2018. PMID: 30055750 Review.

9

JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes.

Bittner VA, Jacobson TA, Ballantyne CM, Guyton JR. Bittner VA, et al. J Clin Lipidol. 2020 Jan-Feb;14(1):4-15. doi: 10.1016/j.jacl.2020.02.004. J Clin Lipidol. 2020. PMID: 32192643 Review.

10

Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction.

Colvin CL, Poudel B, Bress AP, Derington CG, King JB, Wen Y, Chen L, Bittner V, Brown TM, Monda KL, Mues KE, Rosenson RS, Jackson EA, Muntner P, Colantonio LD. Colvin CL, et al. J Clin Lipidol. 2021 Sep-Oct;15(5):665-673. doi: 10.1016/j.jacl.2021.08.001. Epub 2021 Aug 10. J Clin Lipidol. 2021. PMID: 34452823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page